Xenova Acquires KS Biomedix to Focus on Brain Cancer Drug
By Business Review Editor
Pharma Deals Review: Vol 2003 Issue 40 (Table of Contents)
Published: 3 Oct-2003
DOI: 10.3833/pdr.v2003.i40.864 ISSN: 1756-7874
Section: Mergers & Acquisitions
Fulltext:
Abstract
Xenova entered into an agreement to acquire KS Biomedix, thus substantially expanding its Brain cancer drug product portfolio...
This page is available to subscribers only.
Not a subscriber? Join here
Already Registered? Please login using the top left purple box.
Copyright: © IQVIA 2018
RSS